|
LMBR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.531800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.281000E-01 |
| Normal-vs-Stage2 |
2.042400E-01 |
| Normal-vs-Stage3 |
3.777600E-01 |
| Normal-vs-Stage4 |
7.670800E-01 |
| Stage1-vs-Stage2 |
6.631000E-01 |
| Stage1-vs-Stage3 |
2.183800E-02 |
| Stage1-vs-Stage4 |
1.791650E-01 |
| Stage2-vs-Stage3 |
4.040200E-02 |
| Stage2-vs-Stage4 |
1.576170E-01 |
| Stage3-vs-Stage4 |
6.470000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.513000E-01 |
| Normal-vs-AfricanAmerican |
2.116000E-01 |
| Normal-vs-Asian |
4.953200E-01 |
| Caucasian-vs-AfricanAmerican |
2.216600E-01 |
| Caucasian-vs-Asian |
6.109400E-01 |
| AfricanAmerican-vs-Asian |
4.686800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.068600E-01 |
| Normal-vs-Female |
3.774000E-01 |
| Male-vs-Female |
5.473600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.286420E-01 |
| Normal-vs-Age(41-60Yrs) |
8.112600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.521400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.164000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.476790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.034600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.243800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.637200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.620000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.909000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.14730000000141E-05 |
| Classical-VS-Follicular |
9.001600E-01 |
| Classical-VS-Other |
3.177800E-01 |
| Classical-VS-Normal |
1.720570E-01 |
| Tall-VS-Follicular |
1.142530E-03 |
| Tall-VS-Other |
5.385200E-01 |
| Tall-VS-Normal |
1.542190E-02 |
| Follicular-VS-Other |
3.652200E-01 |
| Follicular-VS-Normal |
3.449000E-01 |
| Other-VS-Normal |
4.461400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.444800E-01 |
| Normal-vs-N1 |
1.585960E-01 |
| N0-vs-N1 |
3.101900E-02 |
|
|
